AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2003854 — intervention group
Group type: EXPERIMENTAL
Intervention: Deflazacort
Number of subjects: 26
Study 2003854 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 26
Study 2003854 — intervention group
Group type: COMPARATOR
Intervention: Neither corticosteroid
Number of subjects: 26
Study 6340444 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous diazepam (5 mg)
Number of subjects: 284
Study 6340444 — intervention group
Group type: COMPARATOR
Intervention: No diazepam (Control)
Number of subjects: 284
Study 31859559 — intervention group
Group type: EXPERIMENTAL
Intervention: Collision with a person announcement
Number of subjects: 664
Study 31859559 — intervention group
Group type: COMPARATOR
Intervention: Emergency services announcement
Number of subjects: 664
Study 28236984 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2510924 + carboplatin/etoposide (LY+SOC)
Number of subjects: 94
Study 28236984 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin/etoposide alone (SOC)
Number of subjects: 94
Study 26812001 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation
Number of subjects: 239
Study 24255767 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI observations at RTP
Number of subjects: 53
Study 22855917 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified hypocaloric diet (MHCD) with high-protein, low-glycemic load (30% of daily energy from protein)
Number of subjects: 60
Study 22855917 — intervention group
Group type: COMPARATOR
Intervention: Conventional hypocaloric diet (CHCD) (15% of daily energy from protein)
Number of subjects: 60
Study 20718543 — intervention group
Group type: EXPERIMENTAL
Intervention: Countercultural norms emphasizing nurturing the less capable in the United States
Number of subjects: 0
Study 20718543 — intervention group
Group type: EXPERIMENTAL
Intervention: Countercultural norms emphasizing competitive achievement in the Netherlands
Number of subjects: 0
Study 17694344 — intervention group
Group type: EXPERIMENTAL
Intervention: c9,t11-18:2
Number of subjects: 12
Study 17694344 — intervention group
Group type: EXPERIMENTAL
Intervention: t10,c12-18:2
Number of subjects: 12
Study 17694344 — intervention group
Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 12
Study 17694344 — intervention group
Group type: EXPERIMENTAL
Intervention: c9,t11-18:2 and t10,c12-18:2
Number of subjects: 12
Study 17694344 — intervention group
Group type: EXPERIMENTAL
Intervention: Body fatness
Number of subjects: 12
Study 15867002 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant treatment (1 g vitamin C and 1 g vitamin E daily for 2 months)
Number of subjects: 64
Study 15867002 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 12236630 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 million units subcutaneous IFN-alpha
Number of subjects: 0
Study 12236630 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9808216 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet (HF) with dexfenfluramine (DF)
Number of subjects: 6
Study 9808216 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet (LF) with dexfenfluramine (DF)
Number of subjects: 6
Study 9808216 — intervention group
Group type: COMPARATOR
Intervention: High-fat diet (HF) with placebo (PL)
Number of subjects: 6
Study 9808216 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (LF) with placebo (PL)
Number of subjects: 6
Study 9808216 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexfenfluramine (DF)
Number of subjects: 6
Study 7569514 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant hirudin
Number of subjects: 0
Study 7569514 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian population pharmacokinetic/pharmacodynamic model
Number of subjects: 0
Study 2666137 — intervention group
Group type: EXPERIMENTAL
Intervention: Totally implanted access systems (TI)
Number of subjects: 96
Study 2666137 — intervention group
Group type: COMPARATOR
Intervention: Classical external catheters (CE)
Number of subjects: 96
Study 31881911 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal manual therapy (MT) treatment
Number of subjects: 0
Study 31881911 — intervention group
Group type: COMPARATOR
Intervention: Usual care by the general practitioner (GP)
Number of subjects: 0
Study 29850922 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified multifactorial intervention
Number of subjects: 160
Study 29850922 — intervention group
Group type: COMPARATOR
Intervention: Conventional multifactorial intervention
Number of subjects: 160
Study 26891118 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine supplementation (150 μg of iodine as potassium iodate daily for 24 weeks)
Number of subjects: 112
Study 26891118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 26891118 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine supplementation
Number of subjects: 112
Study 24055845 — intervention group
Group type: COMPARATOR
Intervention: Apixaban
Number of subjects: 14897
Study 24055845 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 14897
Study 24055845 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity troponin T (hs‐TnT) levels
Number of subjects: 14897
Study 24055845 — intervention group
Group type: EXPERIMENTAL
Intervention: hs‐TnT quartiles
Number of subjects: 14897
Study 24055845 — intervention group
Group type: EXPERIMENTAL
Intervention: hs‐TnT levels added to CHA2DS2VASc score
Number of subjects: 14897
Study 23027488 — intervention group
Group type: EXPERIMENTAL
Intervention: Stand-alone anchored spacers (group A, n=23)
Number of subjects: 51
Study 23027488 — intervention group
Group type: COMPARATOR
Intervention: Anterior plate (group B, n=28)
Number of subjects: 51
Study 19125778 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin 12.5 mg
Number of subjects: 500
Study 19125778 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin 25 mg
Number of subjects: 500
Study 19125778 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study 19125778 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin 12.5 mg and 25 mg
Number of subjects: 500
Study 17493152 — intervention group
Group type: EXPERIMENTAL
Intervention: LTA 252GG genotype
Number of subjects: 0
Study 17493152 — intervention group
Group type: COMPARATOR
Intervention: LGALS2 polymorphism
Number of subjects: 0
Study 16198981 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimorazole
Number of subjects: 320
Study 16198981 — intervention group
Group type: COMPARATOR
Intervention: Nimorazole (high osteopontin concentration)
Number of subjects: 320
Study 16198981 — intervention group
Group type: COMPARATOR
Intervention: Placebo (low osteopontin concentration)
Number of subjects: 320
Study 16198981 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intermediate osteopontin concentration)
Number of subjects: 320
Study 12421198 — intervention group
Group type: EXPERIMENTAL
Intervention: REM with propofol
Number of subjects: 120
Study 12421198 — intervention group
Group type: EXPERIMENTAL
Intervention: REM with desflurane
Number of subjects: 120
Study 12421198 — intervention group
Group type: EXPERIMENTAL
Intervention: REM with sevoflurane
Number of subjects: 120
Study 12421198 — intervention group
Group type: COMPARATOR
Intervention: Conventional anesthetic (thiopentone, alfentanil, isoflurane, N2O)
Number of subjects: 120
Study 10522993 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibandronate infusion (dosage not specified)
Number of subjects: 315
Study 8569226 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol
Number of subjects: 34
Study 8569226 — intervention group
Group type: COMPARATOR
Intervention: sotalol
Number of subjects: 34
Study 1952135 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (1.0 mg/kg)
Number of subjects: 10
Study 1952135 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol (0.3 mg/kg)
Number of subjects: 10
Study 1952135 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (1.5 micrograms/kg)
Number of subjects: 10
Study 1952135 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (1.0 mg/kg)
Number of subjects: 10
Study 1952135 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (control)
Number of subjects: 10
Study 7150394 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental diet (vegetarianism)
Number of subjects: 15
Study 7150394 — intervention group
Group type: COMPARATOR
Intervention: Control diet (usual intake in the U.S.A.)
Number of subjects: 15
Study 31414891 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of any of 10 CT features for complicated appendicitis
Number of subjects: 100
Study 31414891 — intervention group
Group type: COMPARATOR
Intervention: Gestalt assessment by radiologists
Number of subjects: 100
Study 28551197 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C + sodium bicarbonate
Number of subjects: 160
Study 28551197 — intervention group
Group type: COMPARATOR
Intervention: Sodium bicarbonate alone
Number of subjects: 160
Study 25327828 — intervention group
Group type: EXPERIMENTAL
Intervention: FeNO-guided algorithm
Number of subjects: 0
Study 25327828 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 0
Study 23419340 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (group Des)
Number of subjects: 332
Study 21826541 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week internet-based prevention program (icd-forum.de)
Number of subjects: 0
Study 21826541 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based psychosocial care
Number of subjects: 0
Study 19321528 — intervention group
Group type: EXPERIMENTAL
Intervention: Trapeziectomy with Flexor carpi radialis ligament reconstruction, tendon interposition and Kirschner wire insertion followed by splintage for 6 weeks (T+LRTI)
Number of subjects: 128
Study 19321528 — intervention group
Group type: COMPARATOR
Intervention: Excision of the trapezium with no Kirschner wire and immobilisation of the thumb in a soft bandage for only 3 weeks (T)
Number of subjects: 128
Study 17709710 — intervention group
Group type: EXPERIMENTAL
Intervention: TCH346 (1.0, 2.5, 7.5, or 15 mg/day)
Number of subjects: 591
Study 17709710 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 591
Study 17709710 — intervention group
Group type: EXPERIMENTAL
Intervention: TCH346
Number of subjects: 591
Study 14722031 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese men
Number of subjects: 42
Study 14722031 — intervention group
Group type: COMPARATOR
Intervention: Lean men
Number of subjects: 42
Study 11847921 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated bednets
Number of subjects: 0
Study 11847921 — intervention group
Group type: COMPARATOR
Intervention: House spraying with deltamethrin
Number of subjects: 0
Study 10456137 — intervention group
Group type: COMPARATOR
Intervention: Oxygen injector
Number of subjects: 46
Study 10456137 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation (Ohmedia 7000 ventilator)
Number of subjects: 46
Study 8042757 — intervention group
Group type: EXPERIMENTAL
Intervention: flunitrazepam/fentanyl (0.01 mg/kg for induction, 1.2 mg/h for maintenance)
Number of subjects: 30
Study 8042757 — intervention group
Group type: EXPERIMENTAL
Intervention: etomidate (0.25 mg/kg) and fentanyl (0.005 mg/kg) for induction, isoflurane (0.6‐1.2 vol%)/fentanyl (1.2 mg/h) for maintenance
Number of subjects: 30
Study 8042757 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group)
Number of subjects: 30
Study 3381314 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine sulphate
Number of subjects: 0
Study 3381314 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine hydrochloride
Number of subjects: 0
Study 3381314 — intervention group
Group type: EXPERIMENTAL
Intervention: Fansidar
Number of subjects: 0
Study 3381314 — intervention group
Group type: COMPARATOR
Intervention: Control (no antimalarial agents)
Number of subjects: 0
Study 28695977 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid coronary revascularization (HCR)
Number of subjects: 200
Study 28695977 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 200
Study 27906104 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based mindfulness intervention
Number of subjects: 0
Study 27906104 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 0
Study 24400937 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational intervention (MI)
Number of subjects: 140
Study 24400937 — intervention group
Group type: COMPARATOR
Intervention: Brief advice (BA)
Number of subjects: 140
Study 22623383 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (4 mg iron/L, 13.1 g protein/L)
Number of subjects: 31
Study 22623383 — intervention group
Group type: EXPERIMENTAL
Intervention: α‐Lactalbumin-enriched infant formula (α‐LAC)
Number of subjects: 31
Study 22623383 — intervention group
Group type: EXPERIMENTAL
Intervention: α‐Lactalbumin-enriched/casein‐glycomacropeptide‐reduced infant formula (α‐LAC/RGMP)
Number of subjects: 31
Study 22623383 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 31
Study 22623383 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula-fed infants with iron deficiency
Number of subjects: 31
Study 22623383 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula-fed infants
Number of subjects: 31
Study 20837163 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based hypertension feedback
Number of subjects: 500
Study 20837163 — intervention group
Group type: COMPARATOR
Intervention: Web-based preventive health feedback
Number of subjects: 500
Study 17848393 — intervention group
Group type: EXPERIMENTAL
Intervention: ramipril (5 mg BID)
Number of subjects: 528
Study 17848393 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 528
Study 16392975 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy plus cognitive-behavioral (MET-CB) treatment
Number of subjects: 450
Study 16392975 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy (MET)
Number of subjects: 450
Study 16392975 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment control group
Number of subjects: 450
Study 12399280 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine intake estimated by food‐frequency questionnaire
Number of subjects: 4649
Study 12399280 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine intake from diet plus supplements
Number of subjects: 4649
Study 12399280 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine intake from diet/kg body weight
Number of subjects: 4649
Study 12399280 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk intake
Number of subjects: 4649
Study 12399280 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary iodine excretion measured as a concentration
Number of subjects: 4649
Study 12399280 — intervention group
Group type: EXPERIMENTAL
Intervention: All measures of iodine intake
Number of subjects: 4649
Study 12399280 — intervention group
Group type: EXPERIMENTAL
Intervention: Some measures of iodine intake
Number of subjects: 4649
Study 10467958 — intervention group
Group type: EXPERIMENTAL
Intervention: H2‐receptor antagonist (n = 196)
Number of subjects: 312
Study 10467958 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (n = 116)
Number of subjects: 312
Study 7826063 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT combined therapy group (UFT, DESP, and castration)
Number of subjects: 92
Study 7826063 — intervention group
Group type: COMPARATOR
Intervention: Hormonal therapy alone group (DESP and castration)
Number of subjects: 92
Study 1369703 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (60 mg daily)
Number of subjects: 1736
Study 6996626 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous metronidazole
Number of subjects: 0
Study 6996626 — intervention group
Group type: COMPARATOR
Intervention: Oral metronidazole
Number of subjects: 0
Study 30816732 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain management program with clinician support
Number of subjects: 397
Study 27759074 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg or 400 mg γδ‐T3 emulsions
Number of subjects: 30
Study 27759074 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 26026286 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine therapy (2.5 mg b.i.d. for 14 days and 2.5 mg q.d. from day 15 to 56) plus best supportive care (BSC)
Number of subjects: 60
Study 26026286 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care (BSC) plus 1 week of low-dose bromocriptine (2.5 mg q.d.) with anticoagulant therapy at a prophylactic dose
Number of subjects: 60
Study 26026286 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Bromocriptine and control)
Number of subjects: 60
Study 23375680 — intervention group
Group type: EXPERIMENTAL
Intervention: DPP-IV inhibitors (sitagliptin and vildagliptin)
Number of subjects: 90
Study 23375680 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin
Number of subjects: 90
Study 23375680 — intervention group
Group type: EXPERIMENTAL
Intervention: DPP-IV inhibitors
Number of subjects: 90
Study 20553148 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin antibiotic prophylaxis
Number of subjects: 100
Study 20553148 — intervention group
Group type: COMPARATOR
Intervention: Different amoxicillin regimens
Number of subjects: 100
Study 19436275 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori eradication group receiving 1-week triple therapy (n=105)
Number of subjects: 325
Study 19436275 — intervention group
Group type: COMPARATOR
Intervention: H. pylori-positive non-eradication controls (n=105)
Number of subjects: 325
Study 19436275 — intervention group
Group type: COMPARATOR
Intervention: H. pylori-negative controls (n=115)
Number of subjects: 325
Study 19436275 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori eradication group
Number of subjects: 325
Study 16750246 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 80 mg
Number of subjects: 1133
Study 16750246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1133
Study 14993498 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrate-taurolidine-containing solution
Number of subjects: 58
Study 14993498 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 58
Study 11240235 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term hormones (LTH) - goserelin starting the last week of RT and continued indefinitely.
Number of subjects: 993
Study 11240235 — intervention group
Group type: COMPARATOR
Intervention: Short-term hormones (STH) - goserelin and flutamide 2 months prior to and during RT.
Number of subjects: 993
Study 11240235 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy (RT) alone.
Number of subjects: 993
Study 9512280 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure cut current
Number of subjects: 170
Study 9512280 — intervention group
Group type: COMPARATOR
Intervention: Blended current
Number of subjects: 170
Study 8070927 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg fluconazole orally over 5 days
Number of subjects: 23
Study 8070927 — intervention group
Group type: COMPARATOR
Intervention: 100 mg fluconazole for 10-21 days
Number of subjects: 23
Study 8070927 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg fluconazole
Number of subjects: 23
Study 8070927 — intervention group
Group type: EXPERIMENTAL
Intervention: C. albicans isolates
Number of subjects: 23
Study 8070927 — intervention group
Group type: EXPERIMENTAL
Intervention: Candida spp. other than C. albicans
Number of subjects: 23
Study 3281775 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg inhaled diltiazem
Number of subjects: 10
Study 3281775 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg inhaled diltiazem
Number of subjects: 10
Study 3281775 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg inhaled diltiazem
Number of subjects: 10
Study 3281775 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg inhaled diltiazem
Number of subjects: 10
Study 3281775 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg inhaled diltiazem
Number of subjects: 10
Study 3281775 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3281775 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose diltiazem (20 to 45 mg)
Number of subjects: 10
Study 31059836 — intervention group
Group type: EXPERIMENTAL
Intervention: CephX® online website-based platform
Number of subjects: 30
Study 31059836 — intervention group
Group type: COMPARATOR
Intervention: FACAD® computer software
Number of subjects: 30
Study 28965646 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq® optical laryngoscope
Number of subjects: 80
Study 28965646 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 80
Study 27692976 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg once daily for 5 days
Number of subjects: 22
Study 25608582 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep breathing test (DBT) + sequential standard BP measurement
Number of subjects: 214
Study 25608582 — intervention group
Group type: COMPARATOR
Intervention: Sequential standard BP measurement only
Number of subjects: 214
Study 23312003 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity Internet-delivered psychotherapy + improved treatment as usual (ITAU) by GP
Number of subjects: 450
Study 23312003 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-guided Internet-delivered psychotherapy + ITAU
Number of subjects: 450
Study 23312003 — intervention group
Group type: COMPARATOR
Intervention: ITAU
Number of subjects: 450
Study 23312003 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity Internet-delivered psychotherapy + ITAU
Number of subjects: 450
Study 21658716 — intervention group
Group type: EXPERIMENTAL
Intervention: Miglustat treatment
Number of subjects: 0
Study 21658716 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17477451 — intervention group
Group type: EXPERIMENTAL
Intervention: Life Review Group Program (LRGP) for 8 weeks
Number of subjects: 75
Study 17477451 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 75
Study 16506965 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% fish oil (FO)
Number of subjects: 58